#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Macular telangiectasia Paraneoplastic neurological syndrome Atopic keratoconjunctivitis Activated PI3 kinase delta syndrome Ocular myasthenia Desmoid tumour Ewing's sarcoma metastatic Acquired haemophilia Stevens-Johnson syndrome Langerhans' cell histiocytosis B-cell small lymphocytic lymphoma refractory Arrhythmogenic right ventricular dysplasia Angiosarcoma recurrent Dedifferentiated liposarcoma Warm autoimmune haemolytic anaemia More trials…

    Learn about Rare Diseases

    Glomerulonephritis rapidly progressive – Trials in Disease Mantle cell lymphoma stage II Malignant fibrous histiocytoma – Basic Information Leukoencephalopathy Haemophilia A with anti factor VIII – Diagnostics Alternating hemiplegia of childhood – Diagnostics Cerebral arteriovenous malformation haemorrhagic – Trials in Disease Leiomyosarcoma recurrent Nephroblastoma Metachromatic leukodystrophy – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Methadone Hydrochloride Ravulizumab GSKVX000000025896 Suvecaltamide L-Arginine Hydrochloride ATOVAQUONE Gadoxetic Acid, Disodium Mocravimod Triamcinolone Melphalan Flufenamide Bisoprolol Poractant Alfa ALLERGEN EXTRACTS Censavudine Isotretinoin Dazucorilant Vesleteplirsen Alglucosidase Alfa Chlorambucil Linaclotide More therapies…

    Learn about Your Condition

    Encephalitis Japanese B Graves' disease Chronic coronary syndrome Aortic stenosis Hepatic fibrosis Bile duct adenocarcinoma Supraventricular tachycardia Small for dates baby Hypochromic anaemia Thermal burn Skin bacterial infection Behavioural addiction COVID-19 Choroidal neovascularisation Eructation More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Vaccine

  • Comparing brincidofovir and cidofovir for treating adenovirus infection in children and adults after stem cell transplantation

    Recruiting

    3 1 1
    Investigated Diseases:
    • Adenovirus infection
    Investigated Drugs:
    • Anhydrous Cidofovir
    France Germany Italy Spain

  • Study of glucagon effects on physical capacity in patients with heart failure with preserved ejection fraction (HFpEF) with or without liver steatosis

    Recruiting

    2 1 1
    Investigated Drugs:
    • Glucagon
    • Human Plasma Protein
    Germany

  • Study of intra-arterial angiotensin II during radioembolization to improve treatment effectiveness in patients with primary or secondary liver cancer

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Hepatic cancer
    Investigated Drugs:
    • ANGIOTENSIN II
    The Netherlands

  • Study of iodofalan (131I) and lomustine combination therapy compared to lomustine alone in patients with first recurrent glioblastoma

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Glioblastoma
    Investigated Drugs:
    • 4-IODOPHENYLALANINE I-131
    • Lomustine
    Austria Belgium Denmark France Germany The Netherlands +1

  • A study evaluating the effects of intravenous lidocaine on pain control and recovery after colon cancer surgery

    Recruiting

    2 1 1
    Investigated Diseases:
    • Colon cancer
    Investigated Drugs:
    • Sodium Chloride
    • Lidocaine Hydrochloride Monohydrate
    Slovenia

  • Evaluation of CIT-013 at two dose levels compared to placebo for treating moderate to severe Hidradenitis Suppurativa

    Recruiting

    2 1
    Investigated Diseases:
    • Hidradenitis
    Germany The Netherlands Poland Spain
Previous Page
1 … 125 126 127 128 129 … 1,648
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!